Drug

Company

Purpose

Date

Zubsolv®. Zubsolv®

(buprenorphine

and naloxone)

Orexo AB

treatment of opioid dependence

July 2013

Vivitrol®

extended-release naltrexone

Alkermes

prevention of relapse to

opioid dependence

October 2010

Vivitrol®

Naltrexone

Alkermes

treatment of alcohol dependence

April 2006

CHANTIX®

(varenicline),

Pfizer

treatment of nicotine addiction

May 2006

acamprosate calcium

Campral

treatment of alcoholism

2004

Suboxone®

(buprenorphine/naloxone)

Subutex®

(buprenorphine)

Reckitt

Benckiser

treatment of

opiate dependence

October 2002

NicoDerm CQ ®

Nicorette®

Glaxo-SmithKline

for smoking cessation

Naltrexone Hydrochloride

oral tablets

Dupont

tablet form (50 mg taken daily)

for the treatment of alcoholism

1994

Antabuse®

(disulfiram)

Odyssey

Pharmaceuticals

Treatment of alcohol dependence

1951